Kala Bio Return on Net Operating Assets Analysis

Kala Bio, Inc. (KALA)

2.23 -0.06 (-2.62%) USD | NASDAQ | May 29, 16:00

2.23 0.00 (0.00%) Pre-Market: 20:00

View Return on Net Operating Assets for KALA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Acurx Pharmaceuticals, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Anika Therapeutics, Inc.	Upgrade
Savara, Inc.	Upgrade